HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-β-D-glucopyanosylspinasterol via blocking NF-κB and STAT1 signaling pathways in TNF-α and IFN-γ-induced HaCaT keratinocytes.

Abstract
A phytosterol derivative, 3-O-β-D-glucopyanosylspinasterol (spinasterol-Glc) isolated from leaves of Stewartia koreana was reported to inhibit LPS-induced cytokine production in macrophage cells. Thymus and activation regulated chemokine (TARC/CCL17) is produced in response to pro-inflammatory cytokines in keratinocytes, which is implicated in the development of inflammatory skin diseases. In present study, we investigated the effect of spinasterol-Glc on production of TARC/CCL17 induced by TNF-α and IFN-γ in human HaCaT keratinocytes. Spinasterol-Glc inhibited the mRNA and protein expression of TARC/CCL17 induced by TNF-α/IFN-γ in a dose-dependent manner. Inhibitors of c-Raf-1, p38 MAPK, and JAK2, suppressed the TNF-α/IFN-γ-induced production of TARC/CCL17, and phosphorylation of these signaling molecules were attenuated by spinasterol-Glc. The compound also inhibited phosphorylation of IKKα/β and IκB-α, and reduced translocation of NF-κB to the nucleus. We demonstrated that spinasterol-Glc suppressed the NF-κB-driven and the GAS-driven expression of luciferase reporter gene induced by TNF-α and IFN-γ. In addition, spinasterol-Glc inhibited the DNA binding of NF-κB and STAT1 to its cognate binding site. These results suggest that spinasterol-Glc has effective inhibitory effects on production of TARC/CCL17 in keratinocytes via inhibition of NF-κB as well as STAT activation, and could be utilized for development of a potential therapeutic agent against skin inflammatory diseases.
AuthorsMi-ra Jung, Tae Hoon Lee, Myun-Ho Bang, Hakwon Kim, Youngsook Son, Dae Kyun Chung, Jiyoung Kim
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 427 Issue 2 Pg. 236-41 (Oct 19 2012) ISSN: 1090-2104 [Electronic] United States
PMID22943853 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • 3-O-beta-D-glucopyranosyl-spinasterol
  • Anti-Inflammatory Agents, Non-Steroidal
  • CCL17 protein, human
  • Chemokine CCL17
  • Dermatologic Agents
  • NF-kappa B
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Stigmasterol
  • JAK2 protein, human
  • Janus Kinase 2
  • Proto-Oncogene Proteins c-raf
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Cell Line
  • Chemokine CCL17 (antagonists & inhibitors, biosynthesis)
  • Dermatitis, Atopic (drug therapy, metabolism)
  • Dermatologic Agents (pharmacology)
  • Humans
  • Interferon-gamma (pharmacology)
  • Janus Kinase 2 (metabolism)
  • Keratinocytes (drug effects, metabolism)
  • NF-kappa B (antagonists & inhibitors)
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-raf (metabolism)
  • STAT1 Transcription Factor (antagonists & inhibitors)
  • Signal Transduction (drug effects)
  • Stigmasterol (analogs & derivatives, pharmacology)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: